Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > Marketing Direct > Direct Mail Marketing is a Rifle, Not a Shotgun, Says Direct Response Advertising Services Company

Tags

  • packaged
  • people
  • device
  • combination products
  • chief operating

  • Links

  • Cheap Flights Dubai
  • Creating A Blog For Internet Marketing
  • Philadelphia Used Car Insurance
  • Digg It - Direct Mail Marketing is a Rifle, Not a Shotgun, Says Direct Response Advertising Services Company

    When I served in the British Special Forces, I learned a lesson from a sniper that applies directly to your success at direct mail mar
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    keting.

    I had a buddy in my Reconnaissance Troop who could kill a man at 800 metres with one bullet, even if the man was walking. Sco
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    tie was a sniper. His motto was the motto of all snipers, “One round, one kill.”

    The job of a sniper in wartime is to kill specific p
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    ople at specific places at specific times. Snipers don’t engage all the enemy on all fronts. Instead, they are given orders to kill
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    high-value targets.” And they are expected to kill those people with one shot from a concealed position. They shouldn’t expect a secon
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    chance. Which means each bullet (each “round”) has someone’s name on it, so to speak.

    I remember Scottie whenever I am talking with
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    a client or prospective client who wants to use direct mail to reach the masses. Someone who wants to use direct mail as a shotgun s
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    that everyone in its path receives the sales pitch.

    But direct mail marketing isn’t mass marketing. It’s a sniper rifle. With a snip
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    r scope mounted on top. Direct mail marketing is all about putting one individual in your crosshairs and firing one message at that
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    erson. Newspaper advertising targets the masses. Direct mail marketing targets one individual.

    Direct mail is too accurate a weapon t
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    be used simply for raising awareness. And it’s too expensive to use to reach the masses, since most individuals in the masses will
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    never buy from you.

    So your first job as a direct mail marketer is to segment your market. Narrow your focus to those individuals who
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    want and can afford what you are selling. They will usually fall into different groups.

    One group might be chief operating officers a
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    non-profit teaching hospitals in cities of 400,000 people or greater, at hospitals with more than 700 beds.

    Another group might be
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    chief financial officers at rural hospitals that have 200 beds or fewer, and that are operated as corporations.

    Your next job is to n
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    rrow your offer. Your offer for the chief operating officer at the large, non-profit, urban hospital should be different from your off
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    er for the chief financial officer at the small, for-profit, rural hospital. Their needs are different. So your messages and offers
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ust be different. Each market segment gets a different bullet.

    Using direct mail as a sniper rifle instead of a shotgun means you wil
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    mail fewer packages to fewer people. Which means your cost to reach each individual will be higher. But it also means your response r
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    tes will be higher. And your cost per sale, and your cost per qualified lead, will be lower. That’s the beauty of one shot, one sale


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/30446/diggit-Direct-Mail-Marketing-is-a-Rifle-Not-a-Shotgun-Says-Direct-Response-Advertising-Services-Company.html">Direct Mail Marketing is a Rifle, Not a Shotgun, Says Direct Response Advertising Services Company</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/30446/diggit-Direct-Mail-Marketing-is-a-Rifle-Not-a-Shotgun-Says-Direct-Response-Advertising-Services-Company.html]Direct Mail Marketing is a Rifle, Not a Shotgun, Says Direct Response Advertising Services Company[/url]

    Related Articles:

    When a Customer Has Done Everything to Get Your Goat

    AGLOCO - Pyramid Scheme

    Difficult Staff - It Pays To Get To Know Them Better

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com